Search

Displaying results 1751 - 1760 of 8974 in total
  1. Indication

    Burns first degree

    go.drugbank.com/conditions/DBCOND0015343
    Drugs: Centella asiatica · Nepidermin · Pheniramine · St. John's Wort · Zinc oxide
    Synonyms: Erythema due to burn (first degree), unspecified site
  2. Indication

    Cognitive Dysfunctions

    go.drugbank.com/conditions/DBCOND0063316
    Drugs: Choline alfoscerate · Ginkgo biloba · Piracetam · Pyritinol
    Synonyms: Mild neurocognitive disorder due to known physiological condition
  3. Indication

    Osteoporosis caused by Glucocorticoid Treatment

    go.drugbank.com/conditions/DBCOND0129307
    Drugs: Alendronic acid · Denosumab · Nandrolone · Raloxifene · Teriparatide · Zoledronic acid
    Synonyms: Osteoporosis due to corticosteroids (disorder)
  4. Indication

    Rickettsial infectious disorders

    go.drugbank.com/conditions/DBCOND0027750
    Drugs: Doxycycline
    Synonyms: Disease due to Genus Rickettsia
  5. Indication

    Chronic Granulocytic Leukemias

    go.drugbank.com/conditions/DBCOND0143005
    Drugs: Cyclophosphamide
    Synonyms: Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype
  6. Drug

    Peramivir

    go.drugbank.com/drugs/DB06614
    ApprovedInvestigational

    for no more than two days. … The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic.

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  7. Drug

    Fluoxetine

    go.drugbank.com/drugs/DB00472
    ApprovedInvestigationalVet approved

    [A181673] It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies

    Mixtures: PISAURIT FONCategories: Antidepressive Agents Indicated for Depression, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  8. Drug

    Voclosporin

    go.drugbank.com/drugs/DB11693
    ApprovedInvestigational

    Early intervention with voclosporin coupled with a kidney response is believed to prevent irreversible damage to the kidney and lead to better long-term clinical outcomes for patients with LN. … [L31253] In July 2022, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended voclosporin be granted marketing authorization for use in combination with [mycophenolate mofetil]

  9. Drug

    Sotagliflozin

    go.drugbank.com/drugs/DB12713
    ApprovedInvestigational

    [L39734] A similar approval has also been sought in the US, but the FDA has since published a proposal to refuse the approval because the data submitted did not show that it was safe under the proposed … [L39739] On March 22, 2022, the marketing authorization of sotagliflozin for the treatment of type 1 diabetes mellitus was withdrawn by the EMA due to commercial reasons.

  10. Drug

    Fosinopril

    go.drugbank.com/drugs/DB00492
    ApprovedInvestigational

    It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). … Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals

    Categories: Antihypertensive Agents Indicated for Hypertension